Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Autoimmune GFAP astrocytopathy: Prospective evaluation of 90 patients in 1 year.

Dubey D, Hinson SR, Jolliffe EA, Zekeridou A, Flanagan EP, Pittock SJ, Basal E, Drubach DA, Lachance DH, Lennon VA, McKeon A.

J Neuroimmunol. 2018 Aug 15;321:157-163. doi: 10.1016/j.jneuroim.2018.04.016. Epub 2018 Apr 27.

PMID:
29793728
2.

Glycine receptor modulating antibody predicting treatable stiff-person spectrum disorders.

Hinson SR, Lopez-Chiriboga AS, Bower JH, Matsumoto JY, Hassan A, Basal E, Lennon VA, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2018 Jan 23;5(2):e438. doi: 10.1212/NXI.0000000000000438. eCollection 2018 Mar.

3.

IgLON5 antibody: Neurological accompaniments and outcomes in 20 patients.

Honorat JA, Komorowski L, Josephs KA, Fechner K, St Louis EK, Hinson SR, Lederer S, Kumar N, Gadoth A, Lennon VA, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2017 Jul 18;4(5):e385. doi: 10.1212/NXI.0000000000000385. eCollection 2017 Sep.

4.

Autoantibody-induced internalization of CNS AQP4 water channel and EAAT2 glutamate transporter requires astrocytic Fc receptor.

Hinson SR, Clift IC, Luo N, Kryzer TJ, Lennon VA.

Proc Natl Acad Sci U S A. 2017 May 23;114(21):5491-5496. doi: 10.1073/pnas.1701960114. Epub 2017 May 1.

5.

Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients.

Flanagan EP, Hinson SR, Lennon VA, Fang B, Aksamit AJ, Morris PP, Basal E, Honorat JA, Alfugham NB, Linnoila JJ, Weinshenker BG, Pittock SJ, McKeon A.

Ann Neurol. 2017 Feb;81(2):298-309. doi: 10.1002/ana.24881.

PMID:
28120349
6.

Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Novel Meningoencephalomyelitis.

Fang B, McKeon A, Hinson SR, Kryzer TJ, Pittock SJ, Aksamit AJ, Lennon VA.

JAMA Neurol. 2016 Nov 1;73(11):1297-1307. doi: 10.1001/jamaneurol.2016.2549.

PMID:
27618707
7.

Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders.

Hinson SR, Lennon VA, Pittock SJ.

Handb Clin Neurol. 2016;133:377-403. doi: 10.1016/B978-0-444-63432-0.00021-9. Review.

PMID:
27112688
8.

Metabotropic glutamate receptor type 1 autoimmunity: Clinical features and treatment outcomes.

Lopez-Chiriboga AS, Komorowski L, Kümpfel T, Probst C, Hinson SR, Pittock SJ, McKeon A.

Neurology. 2016 Mar 15;86(11):1009-13. doi: 10.1212/WNL.0000000000002476. Epub 2016 Feb 17.

9.

Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study.

Brickshawana A, Hinson SR, Romero MF, Lucchinetti CF, Guo Y, Buttmann M, McKeon A, Pittock SJ, Chang MH, Chen AP, Kryzer TJ, Fryer JP, Jenkins SM, Cabre P, Lennon VA.

Lancet Neurol. 2014 Aug;13(8):795-806. doi: 10.1016/S1474-4422(14)70141-3. Epub 2014 Jul 6.

10.

Astrocytic autoantibody of neuromyelitis optica (NMO-IgG) binds to aquaporin-4 extracellular loops, monomers, tetramers and high order arrays.

Iorio R, Fryer JP, Hinson SR, Fallier-Becker P, Wolburg H, Pittock SJ, Lennon VA.

J Autoimmun. 2013 Feb;40:21-7. doi: 10.1016/j.jaut.2012.07.008. Epub 2012 Aug 18.

11.

Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes.

Hinson SR, Romero MF, Popescu BF, Lucchinetti CF, Fryer JP, Wolburg H, Fallier-Becker P, Noell S, Lennon VA.

Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):1245-50. doi: 10.1073/pnas.1109980108. Epub 2011 Nov 29.

12.

Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.

Hinson SR, McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Pittock SJ.

Arch Neurol. 2009 Sep;66(9):1164-7. doi: 10.1001/archneurol.2009.188.

PMID:
19752309
13.

Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays.

McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Hinson SR, Kryzer TJ, Lucchinetti CF, Weinshenker BG, Wingerchuk DM, Shuster EA, Pittock SJ.

Arch Neurol. 2009 Sep;66(9):1134-8. doi: 10.1001/archneurol.2009.178.

PMID:
19752303
14.

Neurological autoimmunity targeting aquaporin-4.

Hinson SR, McKeon A, Lennon VA.

Neuroscience. 2010 Jul 28;168(4):1009-18. doi: 10.1016/j.neuroscience.2009.08.032. Epub 2009 Aug 20. Review.

PMID:
19699271
15.

AQP4-IgG immunoprecipitation assay optimization.

Apiwattanakul M, McKeon A, Fryer JP, Hinson SR, Pittock SJ, Lennon VA.

Clin Chem. 2009 Mar;55(3):592-4. doi: 10.1373/clinchem.2008.116848. No abstract available.

16.

Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2.

Hinson SR, Roemer SF, Lucchinetti CF, Fryer JP, Kryzer TJ, Chamberlain JL, Howe CL, Pittock SJ, Lennon VA.

J Exp Med. 2008 Oct 27;205(11):2473-81. doi: 10.1084/jem.20081241. Epub 2008 Oct 6.

17.

Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica.

Hinson SR, Pittock SJ, Lucchinetti CF, Roemer SF, Fryer JP, Kryzer TJ, Lennon VA.

Neurology. 2007 Dec 11;69(24):2221-31. Epub 2007 Oct 10.

PMID:
17928579
18.

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.

Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR.

J Exp Med. 2005 Aug 15;202(4):473-7. Epub 2005 Aug 8.

19.

Functional evaluation and cancer risk assessment of BRCA2 unclassified variants.

Wu K, Hinson SR, Ohashi A, Farrugia D, Wendt P, Tavtigian SV, Deffenbaugh A, Goldgar D, Couch FJ.

Cancer Res. 2005 Jan 15;65(2):417-26.

Supplemental Content

Loading ...
Support Center